Colgate-Palmolive Company (CL)
CL stock forecast: what analysts expect
Wall Street analysts covering Colgate-Palmolive Company currently rate the stock a Buy on average, with a mean 12-month price target of $98.95 — +7.2% versus the last price of $92.32. Targets reflect analyst opinion, not a guarantee.
CL historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in CL.
CL annual returns by year
Congress trading in CL
16 members of Congress have disclosed trading CL — 22 purchases and 17 sales worth an estimated $575,501. Most recent disclosure: Sep 23, 2025.
See who in Congress traded CL →Insider activity in CL
CL's own executives and directors have made 0 open-market purchases ($0) and 4 sales ($30.3M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 6, 2026.
| Aug 6, 2026 | Cahill John T | Director | Sell | $389,358 |
| Aug 5, 2026 | Wallace Noel R. | Chairman, President & CEO | Sell | $14.9M |
| Aug 4, 2026 | Wallace Noel R. | Chairman, President & CEO | Sell | $14.8M |
| May 15, 2026 | Malcolm Gregory | EVP and Controller | Sell | $203,412 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
CL Key Statistics
CL in plain English
- P/E ratio (36.3) — how many dollars you pay for each $1 of CL's yearly profit. That's a fairly normal range.
- ROE (267.37%) — how efficiently the company turns shareholders' money into profit. Above ~20% is considered strong.
- Profit margin (9.68%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (2.30%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
CL stock: frequently asked questions
What is Colgate-Palmolive Company's stock price today?
Colgate-Palmolive Company (CL) last traded at $92.32 on the NYSE. Over the past 52 weeks the stock has traded between $74.55 and $99.33.
Is CL stock a buy or a sell?
Wall Street analysts' consensus rating on CL is "Buy", with an average 12-month price target of $98.95 — about +7.2% versus the current price of $92.32. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in CL 10 years ago be worth today?
A $1,000 investment in Colgate-Palmolive Company made 10 years ago would be worth about $1,572 today (dividends reinvested) — a total return of 57%, or 4.6% per year.
Does CL pay a dividend?
Yes. Colgate-Palmolive Company currently pays a dividend yielding about 2.30% per year at today's share price.
What is CL's P/E ratio?
CL trades at a trailing price-to-earnings ratio of 36.3, and 22.5 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade CL stock?
Yes — 16 members of Congress have disclosed trades in CL under the STOCK Act, totaling 22 purchases and 17 sales worth an estimated $575,501.
What is Colgate-Palmolive Company's ticker symbol?
Colgate-Palmolive Company trades under the ticker symbol CL on the NYSE.
Compare CL with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.